If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWeir Group Regulatory News (WEIR)

Share Price Information for Weir Group (WEIR)

Share Price is delayed by 15 minutes
Get Live Data
2,508.00    64.00 (2.62%)
Bid:
2,498.00
Ask:
2,502.00
Spread: 4.00 (0.16%)
Market Cap: £6.51b
WEIR Live PriceLast checked at - London Stock Exchange

Intraday Weir Group Share Chart

Acquisition

15 Aug 2005 08:02

Weir Group PLC15 August 2005 15 August 2005 THE WEIR GROUP PLC AGREES TO ACQUIRE POMPE GABBIONETA SpA The Weir Group PLC ("Weir") is pleased to announce the signing of an agreementto purchase 100% of the issued share capital of Pompe Gabbioneta SpA("Gabbioneta"), a specialist petrochemical pump business located in Milan,Italy. The consideration for the purchase will be €100m (£69.0m*) payable incash on completion. The transaction is expected to complete on or before 30September 2005. The acquisition is expected to be immediately earnings enhancingfollowing completion. Gabbioneta manufactures speciality pumps primarily for thedownstream end of the oil and gas market. The company has a wide range ofcustomers including oil majors and leading engineering contractors and is rankednumber three in the European, Middle East and African petrochemical pump marketwhere it has a significant installed base. For the year to 31 December 2004, Gabbioneta reported sales of €44.8m (£30.9m*); earnings before interest, tax and amortisation (EBITA) of €6.7m (£4.6m*) and profit before tax (PBT) of €3.1m under Italian GAAP. Under IFRS rulesamortisation of €2.5m will not be charged going forward. As at 31 December 2004gross assets were €48.9m (£33.7m*). Unaudited management accounts for the firstsix months of 2005 indicate that both revenues and operating profits are aheadof the prior year. Gabbioneta, which operates from two facilities in Milan, employs 240 people. Thebusiness was established in 1897 and was most recently owned by private equityfunds led by Aksia Group. The acquisition is in line with Weir's strategic objective to grow our ClearLiquid business in higher margin, high growth specialist markets. The Board of Weir believes that the acquisition of Gabbioneta offers manybenefits and opportunities which include: • The acquisition of a well established business with a considerableinstalled base enjoying a high level of customer loyalty and complementarygeographic footprint. • The opportunity to create a global centre of excellence in oil processpumps. • A strengthening of Weir's relationship with many of the world's majoroil producers through increased sales volumes and broader product offerings. • The opportunity to extend Gabbioneta's markets in the USA and Asia,using the Weir name and geographic footprint, and Gabbioneta's existinginstalled base. • The opportunity to obtain further benefits from Weir's recentinvestments in purchasing and manufacturing technologies and systems. Commenting on the acquisition, Mark Selway, Chief Executive said, "This is asignificant development for the Weir Group. Our strategy is focused onconsolidating our position in the specialist pump market and building aportfolio of high quality high margin businesses. The acquisition of Gabbionetaachieves both. "By integrating Gabbioneta into our Clear Liquid Division we will enhance ourportfolio of oil processing products. Furthermore, the creation of an enlargedclient base will provide opportunities to expand our product offering andservices into the oil and gas industry. "We very much look forward to working with the existing Gabbioneta managementand staff, including chief executive Roberto Zecchi, to grow and develop thebusiness into a leading global player in the petrochemical pump market." Further information on the consideration 1. The Weir Group PLC will complete the acquisition pursuant to agreementsentered into with its shareholders with completion dates on or before 30September 2005. Contact details: The Weir Group PLC Available through UBSMark Selway, Chief Executive Tel. 0141 637 7111Helen Walker, Public Relations Manager (Mobile: 07789 032296)The Maitland Consultancy Tel. 020 7379 5151Suzanne Bartch (Mobile: 07769 710 335)Peter Ogden (Mobile: 07811 124 197) --------------------------* The exchange rates used for the above £ sterling equivalents are • 1.45 = £1being the rates prevailing at the close of business on 12 August 2005. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
10th Apr 20243:18 pmRNSDirector/PDMR Shareholding
10th Apr 20242:14 pmRNSDirector/PDMR Shareholding
10th Apr 20242:11 pmRNSDirector/PDMR Shareholding
5th Apr 202411:30 amRNSHolding(s) in Company
21st Mar 202410:44 amRNS2023 Annual Report and 2024 Annual General Meeting
13th Mar 202410:31 amRNSWeir opens new foundry in China
7th Mar 202411:04 amRNSHolding(s) in Company
29th Feb 20247:00 amRNSFull Year Results
27th Feb 20249:47 amRNSDirectorate Change
7th Feb 20248:48 amRNSHolding(s) in Company
6th Feb 20248:13 amRNSWeir achieves ‘A’ score from CDP
31st Jan 20248:07 amRNSDirectorate Change
19th Dec 202310:29 amRNSNew Board Committee and Board Changes
6th Dec 20237:00 amRNSWeir announces 2026 operating margin target of 20%
5th Dec 20233:09 pmRNSDirectorate Change
4th Dec 20231:30 pmRNSWeir study on energy in mining
23rd Nov 20237:00 amRNSWeir acquires SentianAI
14th Nov 20239:54 amRNSDirector/PDMR Shareholding
7th Nov 20239:04 amRNSDirector/PDMR Shareholding
3rd Nov 20233:51 pmRNSHolding(s) in Company
3rd Nov 20233:51 pmRNSHolding(s) in Company
1st Nov 20237:01 amRNSAppointment of Chief Financial Officer
1st Nov 20237:00 amRNSQ3 Trading Update
26th Oct 20231:55 pmRNSHolding(s) in Company
24th Oct 20238:39 amRNSDirectorate Change
2nd Oct 20237:00 amRNSCapital Markets Event – 6 December 2023
18th Aug 20235:13 pmRNSDirector/PDMR Shareholding
18th Aug 20235:00 pmRNSHolding(s) in Company
18th Aug 20232:44 pmRNSDirector/PDMR Shareholding
18th Aug 20232:30 pmRNSDirector/PDMR Shareholding
1st Aug 20237:00 amRNSHalf-year Report
31st Jul 20232:19 pmRNSTotal Voting Rights
28th Jul 20234:45 pmRNSHolding(s) in Company
27th Jul 20237:00 amRNSDirectorate change
27th Jul 20237:00 amRNSAppointment of John Heasley as Finance Director
13th Jul 202311:59 amRNSStabilisation Notice
30th Jun 20233:51 pmRNSTotal Voting Rights
14th Jun 20232:31 pmRNSHolding(s) in Company
12th Jun 20232:50 pmRNSDirector / PDMR Shareholding
8th Jun 20237:00 amRNSPricing of Sustainability-Linked Notes
7th Jun 202311:35 amRNSDirector/PDMR Shareholding
7th Jun 20239:20 amRNSStabilisation Notice
5th Jun 20238:25 amRNSWeir's commitment recognised in CCLA benchmark
1st Jun 20233:34 pmRNSTotal Voting Rights
25th May 20237:30 amRNSDirector Declaration
12th May 20234:42 pmRNSDirector PDMR shareholding
12th May 20238:19 amRNSDirector/PDMR Shareholding
3rd May 202312:55 pmRNSDirector/PDMR Shareholding
3rd May 202312:51 pmRNSTotal Voting Rights
28th Apr 20232:06 pmRNSBoard Committee Change and EE NED Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.